Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Palbociclib | 0.01 | uM | 5 | 156.25 | 28.48 | 76.00 | 71.25 | 1.0667 | 1.1000 |
| SK-BR-3 | Taxol | 0.001 | uM | 5 | 156.25 | 28.48 | 73.00 | 71.25 | 1.0246 | 1.0370 |
| SK-BR-3 | Methotrexate | 0.01 | uM | 5 | 156.25 | 28.48 | 55.00 | 71.25 | 0.7719 | 0.6446 |
| SK-BR-3 | Palbociclib | 0.31623 | uM | 5 | 156.25 | 28.48 | 84.00 | 71.25 | 1.1789 | 1.2650 |
| SK-BR-3 | Palbociclib | 0.0033113 | uM | 5 | 156.25 | 28.48 | 125.00 | 71.25 | 1.7544 | 2.0588 |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 83.00 | 71.25 | 1.1649 | 1.2446 | |
| SK-BR-3 | Palbociclib | 10 | uM | 5 | 156.25 | 28.48 | 85.00 | 71.25 | 1.1930 | 1.2854 |
| SK-BR-3 | Omipalisib | 0.0016596 | uM | 5 | 156.25 | 28.48 | 62.00 | 71.25 | 0.8702 | 0.8005 |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 62.00 | 71.25 | 0.8702 | 0.8005 | |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 46.00 | 71.25 | 0.6456 | 0.4368 | |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 201.00 | 205.75 | 0.9769 | 0.9195 | |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 182.00 | 205.75 | 0.8846 | 0.6118 | |
| SK-BR-3 | Taxol | 0.00033113 | uM | 5 | 312.50 | 138.75 | 242.00 | 205.75 | 1.1762 | 1.6608 |
| SK-BR-3 | Taxol | 0.31623 | uM | 5 | 312.50 | 138.75 | 159.00 | 205.75 | 0.7728 | 0.2708 |
| SK-BR-3 | Methotrexate | 0.031623 | uM | 5 | 312.50 | 138.75 | 221.00 | 205.75 | 1.0741 | 1.2681 |
| SK-BR-3 | Methotrexate | 10 | uM | 5 | 312.50 | 138.75 | 218.00 | 205.75 | 1.0595 | 1.2142 |
| SK-BR-3 | Palbociclib | 0.1 | uM | 5 | 312.50 | 138.75 | 157.00 | 205.75 | 0.7631 | 0.2428 |
| SK-BR-3 | Omipalisib | 0.031623 | uM | 5 | 312.50 | 138.75 | 183.00 | 205.75 | 0.8894 | 0.6274 |
| SK-BR-3 | Taxol | 0.0031623 | uM | 5 | 312.50 | 138.75 | 196.00 | 205.75 | 0.9526 | 0.8363 |
| SK-BR-3 | Methotrexate | 3.1623 | uM | 5 | 312.50 | 138.75 | 198.00 | 205.75 | 0.9623 | 0.8694 |
| SK-BR-3 | Omipalisib | 0.01 | uM | 5 | 312.50 | 138.75 | 209.00 | 205.75 | 1.0158 | 1.0559 |
| SK-BR-3 | Taxol | 0.031623 | uM | 5 | 312.50 | 138.75 | 164.00 | 205.75 | 0.7971 | 0.3420 |
| SK-BR-3 | Omipalisib | 0.31623 | uM | 5 | 312.50 | 138.75 | 173.00 | 205.75 | 0.8408 | 0.4742 |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 289.00 | 205.75 | 1.4046 | 2.6361 | |
| SK-BR-3 | Palbociclib | 0.031623 | uM | 5 | 312.50 | 138.75 | 171.00 | 205.75 | 0.8311 | 0.4444 |